Neuromodulation Market Analysis by Region, Company and Forecasts 2021 Oct. 2016

The Neuromodulation Market (By Application, Technology, Region and Company) and
Forecast to 2021 – Global Analysis report summarizes Market growth can be attributed to
factors such as rising geriatric population, increasing prevalence of neurological diseases,
strong product pipeline offered by the players. In addition, rapid advances in the field of
neuromodulation and development of minimally invasive techniques have greatly expanded
the market. High cost of treatment and negative social perception is restraining the growth
of neuromodulation market.
North America is seen as the dominant player in the Neuromodulation Market followed by
Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the
neuromodulation market is expected to witness the highest growth rate in the Asian region,
with emphasis on India, China, and Japan. These countries are expected to increase
revenues for the manufacturers of devices involved in neuromodulation.
Complete 116 Pages Report is Available @
http://www.rnrmarketresearch.com/neuromodulation-market-by-applicationtechnology-region-and-company-and-forecast-to-2021-global-analysis-marketreport.html .
Spinal cord stimulation segment dominated the neuromodulation market with more than
XX% share in 2015. But its market share will dwindle in the forecasting period due to the
highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will
grasp nearly 20% market share by the year end of 2021.
Chronic Pain is identified as the largest application segment of the neuromodulation market.
Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation
industry. Refractory epilepsy stands at the third spot with more than XX% share in 2015.
Parkinson’s disease holds the fourth highest share being followed by Gastroparesis.
Essential Tremor and Dystonia are the other leading application segment for
neuromodulation market.
Further, prudent analysis has been done on the competitor’s part, where three major
players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude
Medical, Liva Nova and Nevro are the key influencers with their products in the
Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending
distribution networks are few important factors for their dominance.
The research report presents a comprehensive assessment of the market and contains
thoughtful insights, facts, historical data, and statistically supported and industry–validated
market data. It also contains projections using a suitable set of assumptions and
methodologies. The research report provides analysis and information according to
categories such as market segments, application, technology, geographies, companies and
competitive landscape. The report concludes with the profiles of major players in the global
neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and